PRTN3 and rheumatoid arthritis: Compared with ACPA-negative patients, ACPA-positive RA patients exhibit more severe inflammatory infiltration and joint bone erosion, increased disease activity, significantly increased incidence of pain, and poorer prognosis (128, 129).